Syndicated News

This blog is still in BETA

We are aware of any formatting errors. These stories are automatically pulled from RSS feeds. Due to the automated nature of the post, some images may appear small, and some links may not be clickable until our staff has had the opportunity to manicure the postings. Thank you for understanding.

March 04, 2015

FDA Accepts Bayer's Biologics License Application for Investigational ... - PR Newswire (press release)

March 04, 2015/

http://ift.tt/1M5id4s Click to read full article...

FDA Accepts Bayer's Biologics License Application for Investigational ...PR Newswire (press release)"Bayer is committed to continually bringing new therapies to hemophilia A patients who need them," said David Weinreich, M.D., Head, Global Development, Specialty Medicine, Bayer HealthCare Pharmaceuticals. "Today's milestone represents the next step ...

from Hemophilia - Google News http://ift.tt/1M5id4s via IFTTT

Committee of Ten Thousand

ADVOCATES FOR PERSONS WITH HIV/AIDS, HEMOPHILIA, HCV, AND SICKLE CELL

MONITORING THE BLOOD SUPPLY AND PROTECTING PATIENT RIGHTS SINCE 1989

The Committee of Ten Thousand is a grass-roots, peer-led, education, advocacy and support organization. The majority of our constituency is persons with hemophilia who contracted HIV/AIDS from tainted blood products. We work in solidarity with all communities affected by the HIV/AIDS pandemic. COTT advocates for disenfranchised chronic disease communities, especially those communities dependent on a safe national blood supply. We are dedicated to the belief that persons with HIV/AIDS and all chronic diseases can lead productive and healthy lives.

Syndicated News

Syndicated News Feed

FDA Accepts Bayer's Biologics License Application for Investigational ... - PR Newswire (press release)

Committee of Ten Thousand

Quick Links - Sections